Edition:
United Kingdom

Atossa Genetics Inc (ATOS.OQ)

ATOS.OQ on NASDAQ Stock Exchange Capital Market

1.21USD
14 Nov 2018
Change (% chg)

-- (--)
Prev Close
$1.21
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
28,214
52-wk High
$10.68
52-wk Low
$1.13

Latest Key Developments (Source: Significant Developments)

Atossa Genetics Qtrly Loss Per Share $2.90
Monday, 13 Aug 2018 

Aug 13 (Reuters) - Atossa Genetics Inc ::ATOSSA GENETICS ANNOUNCES SECOND QUARTER 2018 FINANCIAL RESULTS AND PROVIDES COMPANY UPDATE.ATOSSA GENETICS INC QTRLY LOSS PER SHARE $2.90.  Full Article

Atossa Genetics Receives Positive Interim Review From Independent Safety Committee In Phase 1 Topical Endoxifen Dose Escalation Study In Men
Tuesday, 24 Apr 2018 

April 24 (Reuters) - Atossa Genetics Inc ::ATOSSA GENETICS RECEIVES POSITIVE INTERIM REVIEW FROM INDEPENDENT SAFETY COMMITTEE IN PHASE 1 TOPICAL ENDOXIFEN DOSE ESCALATION STUDY IN MEN.ATOSSA GENETICS - INDEPENDENT SAFETY COMMITTEE REVIEWED BLINDED DATA FROM FIRST GROUP IN STUDY, CONCLUDED STUDY MAY ADVANCE TO NEXT DOSING LEVEL.  Full Article

Atossa Genetics posts Q3 loss per share ‍$0.18​
Tuesday, 14 Nov 2017 

Nov 14 (Reuters) - Atossa Genetics Inc :Atossa Genetics announces third quarter 2017 financial results and provides company update.Atossa Genetics Inc qtrly loss per share ‍$0.18​.  Full Article

L1 Capital Global Opportunities Master Fund reports 9.01 pct passive stake in ‍atossa Genetics, as of Oct. 26
Friday, 3 Nov 2017 

Nov 3 (Reuters) - L1 Capital Global Opportunities Master Fund Ltd: :L1 capital global opportunities master fund ltd reports 9.01% passive stake in ‍atossa genetics inc, as of october 26, 2017 - SEC filing‍​.  Full Article

Empery Asset Management reports 9.01 pct passive stake in Atossa Genetics
Tuesday, 31 Oct 2017 

Oct 31 (Reuters) - Empery Asset Management LP::Empery Asset Management LP reports 9.01 percent passive stake in Atossa Genetics as of Oct 26 - SEC filing‍​.  Full Article

Atossa Genetics announces pricing of $5.1 million public offering
Thursday, 26 Oct 2017 

Oct 26 (Reuters) - Atossa Genetics Inc :Atossa Genetics announces pricing of $5.1 million public offering of common stock.Says public offering of 11.5 million common shares priced at $0.44per share.  Full Article

Atossa Genetics announces proposed public offering of common stock
Wednesday, 25 Oct 2017 

Oct 25 (Reuters) - Atossa Genetics Inc ::Atossa Genetics announces proposed public offering of common stock.Says ‍intends to offer and sell shares of its common stock in an underwritten public offering​.  Full Article

Atossa Genetics announces preliminary results from Phase 1 study of topical Endoxifen
Thursday, 14 Sep 2017 

Sept 14 (Reuters) - Atossa Genetics Inc ::Atossa Genetics announces preliminary results from Phase 1 study of topical Endoxifen.Atossa Genetics Inc says expects to announce results from oral arm of Phase 1 study in next 30-60 days.Atossa Genetics Inc says ‍all objectives were successfully met in trial​.Atossa Genetics says‍ no clinically significant safety signals,no clinically significant adverse events in participants receiving topical Endoxifen​.  Full Article

Atossa Genetics qtrly loss per share $0.45
Thursday, 11 May 2017 

May 11 (Reuters) - Atossa Genetics Inc ::Atossa Genetics announces first quarter 2017 financial results and provides company update.Qtrly loss per share $0.45.  Full Article

BRIEF-Atossa Genetics Receives Positive Interim Safety Review In Phase 1 Topical Endoxifen Dose Escalation Study

* ATOSSA GENETICS RECEIVES POSITIVE INTERIM SAFETY REVIEW FROM INDEPENDENT SAFETY COMMITTEE IN PHASE 1 TOPICAL ENDOXIFEN DOSE ESCALATION STUDY IN MEN